Clarity starts here
From first signs to clear answers—our genomic sequencing solutions help you connect the clinical dots, faster.
Our database is the largest rare disease data set. GeneDx Infinity™ is powered by data from over 2.5 million tests – informed by nearly 1 million exomes and genomes and more than 7 million phenotypic datapoints. Nearly 50% represent individuals of non-European ancestry.1 This diversity strengthens rare variant classification.
Genomic testing solutions
Why early genomic sequencing matter
Early genetic testing provides critical insights for complex medical conditions. Understanding which genetic variant(s) is causing your patient's symptoms can transform patient care and treatment strategies.
Broad clinical applications
Exome and genome sequencing are supported by clinical recommendations or guidelines for certain indications and used in a wide range of patient populations, especially when standard testing has been inconclusive or the phenotype is complex. GeneDx’s comprehensive testing enables you to bring clarity and direction earlier in the diagnostic process.
Unexplained epilepsy
For patients with unexplained seizures, where a genetic etiology may inform treatment, prognosis, or follow-up.
Autism
When developmental and social communication delays are observed, genomic sequencing expands the search beyond targeted panels.
Cerebral palsy
Patients presenting with motor impairment may have underlying genetic causes that exome or genome testing can reveal.
Developmental disorders
Early identification of underlying genetic diagnoses supports timely intervention and management.
Neonatal & pediatric critical care
Critically ill infants with suspected genetic disorders benefit from rapid and comprehensive testing to guide urgent care decisions.
More coverage for patients
Genomic testing is more accessible than ever. GeneDx accepts all commercial insurance plans, including many in-network contracts with major national and regional payors, as well as Medicaid, Medicare, and Tricare.
